Effect of vaccination on the course of novel coronavirus infection in young patients

Renata R. Kalamova , Dmitry V. Cherkashin , Victor A. Ulyatovsky , Alexandra I. Zarubenko , Islam S. Salakhbekov , Vladimir Yu. Filippov , Dmitriy S. Bogdanov , Evgeny E. Voevodin

Bulletin of the Russian Military Medical Academy ›› 2023, Vol. 25 ›› Issue (4) : 567 -574.

PDF
Bulletin of the Russian Military Medical Academy ›› 2023, Vol. 25 ›› Issue (4) : 567 -574. DOI: 10.17816/brmma529690
Original Study Article
research-article

Effect of vaccination on the course of novel coronavirus infection in young patients

Author information +
History +
PDF

Abstract

The features of the course of the new coronavirus infection in vaccinated and unvaccinated young patients (aged 18–35 years) were assessed. In total, 111 patients with new coronavirus infection were examined, and they were divided into two groups. The first group included 32 people vaccinated against the new coronavirus infection (21 men and 11 women; average age, 22. 31 ± 5. 04 years), and the second group included 79 unvaccinated people (70 men and 9 women; average age, 20. 76 ± 3. 674 years). A direct dependence of hospitalization time on the presence of vaccination was observed. The average volume of erythrocytes was significantly greater in the vaccinated group than in the unvaccinated group, and the average concentration of hemoglobin in erythrocytes was higher in the unvaccinated group, both at disease onset and over time. In addition, in the vaccinated group, the values of inflammatory markers in the blood such as erythrocyte sedimentation rate, C-reactive protein, ferritin, procalcitonin, and D-dimer, increase much faster. According to the results of repeated computed tomography, the unvaccinated group had longer persistence of signs of viral pneumonia. The primary pathology recorded on the electrocardiogram, particularly bradycardia, was more frequently recorded in the unvaccinated group. Overall, most patients, regardless of vaccination, had a mild course of new coronavirus infection. This may indicate a negative dependence of the severity of the new coronavirus infection on the age of the patient. Despite the low risk of developing complications of coronavirus infection at a young age, to prevent and quickly recover from a new coronavirus infection, all age groups are encouraged to receive vaccination, which will reduce the number of hospitalizations, burden on healthcare, and economic costs of medical care.

Keywords

vaccination / hospitalization / young age / new coronavirus infection / signs of viral pneumonia / inflammatory markers / primary pathology

Cite this article

Download citation ▾
Renata R. Kalamova, Dmitry V. Cherkashin, Victor A. Ulyatovsky, Alexandra I. Zarubenko, Islam S. Salakhbekov, Vladimir Yu. Filippov, Dmitriy S. Bogdanov, Evgeny E. Voevodin. Effect of vaccination on the course of novel coronavirus infection in young patients. Bulletin of the Russian Military Medical Academy, 2023, 25(4): 567-574 DOI:10.17816/brmma529690

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Kucheruk TV, Novikova EN, Samartseva MO. Features of the course of the new coronavirus infection COVID-19 in vaccinated patients. Military Medical Journal. 2022;343(11):31–35. (In Russ.). DOI: 10.52424/00269050_2022_343_11_31

[2]

Кучерук Т.В., Новикова Е.Н., Самарцева М.О. Особенности течения новой коронавирусной инфекции COVID-19 у вакцинированных пациентов // Военно-медицинский журнал. 2022. Т. 343, № 11. С. 31–35. DOI: 10.52424/00269050_2022_343_11_31

[3]

Kryukov EV, Trishkin DV, Salukhov VV, Ivchenko EV. Opyt voennoi meditsiny v bor’be s novoi koronavirusnoi infektsiei. Herald of the Russian Academy of Sciences. 2022;92(7):699–706. (In Russ.). DOI: 10.31857/S086958732207009X

[4]

Крюков Е.В., Тришкин Д.В., Салухов В.В., Ивченко Е.В. Опыт военной медицины в борьбе с новой коронавирусной инфекцией // Вестник Российской академии наук. 2022. Т. 92, № 7. С. 699–706. DOI: 10.31857/S086958732207009X

[5]

Andreenko AA, Andreychuk YV, Arsentiev VG, et al. Infektsiya, vyzvannaya SARS-COV-2. Saint-Petersburg: VМА, 2023. 260 p.

[6]

Андреенко А.А., Андрейчук Ю.В., Арсентьев В.Г., и др. Инфекция, вызванная SARS-COV-2. Санкт-Петербург: ВМА, 2023. 260 с.

[7]

Gumilevsky BYu, Moskalev AV, Apchel VYa, Tsygan VN. Old new coronavirus. Bulletin of the Russian Military Medical Academy. 2020;22(2):182–188. (In Russ.). DOI: 10.17816/brmma50070

[8]

Гумилевский Б.Ю., Москалев А.В., Апчел В.Я., Цыган В.Н. Старый новый коронавирус // Вестник Российской военно-медицинской академии. 2020. Т. 22, № 2. С. 182–188. DOI: 10.17816/brmma50070

[9]

Gumilevsky BYu, Moskalev AV, Gumilevskaya OP, et al. Features of immunopathogenesis of a new coronavirus infection. Bulletin of the Russian Military Medical Academy. 2021;23(1):187–198. (In Russ.). DOI: 10.17816/brmma.63654

[10]

Гумилевский Б.Ю., Москалев А.В., Гумилевская О.П., и др. Особенности иммунопатогенеза новой коронавирусной инфекции // Вестник Российской военно-медицинской академии. 2021. Т. 23, № 1. С. 187–198. DOI: 10.17816/brmma.63654

[11]

Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA. 2020;180(7): 934–943. DOI: 10.1001/jamainternmed.2020.0994

[12]

Wu C., Chen X., Cai Y., et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China // JAMA. 2020. Vol. 180, No. 7. Р. 934–943. DOI: 10.1001/jamainternmed.2020.0994

[13]

Vechorko VI, Evsikov EM, Baykova OA, Levchuk NN. Character of hematological parameters change in patients with covid-19. The Russian Journal of Preventive Medicine. 2020;23(8):57–63. (In Russ.). DOI: 10.17116/profmed20202308157

[14]

Вечорко В.И., Евсиков Е.М., Байкова О.А., Левчук Н.Н. Характер изменения гематологических показателей у больных COVID-19 // Профилактическая медицина. 2020. Т. 23, № 8. С. 57–63. DOI: 10.17116/profmed20202308157

[15]

Jiaming L, Yanfeng Y, Yao D, et al. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine. 2017;35(1):10–18. DOI: 10.1016/j.vaccine.2016.11.06454

[16]

Jiaming L., Yanfeng Y., Yao D., et al. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection // Vaccine. 2017. Vol. 35, No. 1. Р. 10–18. DOI: 10.1016/j.vaccine.2016.11.06454

[17]

Huang W, Berube J, McNamara M, et al. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis. Cytometry Part A. 2020;97(8):772–776. DOI: 10.1002/cyto.a.24172

[18]

Huang W., Berube J., McNamara M., et al. Lymphocyte Subset Counts in COVID-19 Patients: A Meta-Analysis // Cytometry A. 2020. Vol. 97, No. 8. Р. 772–776. DOI: 10.1002/cyto.a.24172

[19]

Malik P, Patel U, Mehta D, et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis. BMJ. 2021;26(3):107–108. DOI: 10.1136/bmjebm-2020-111536

[20]

Malik P., Patel U., Mehta D., et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis // BMJ. 2021. Vol. 26, No. 3. Р. 107–108. DOI: 10.1136/bmjebm-2020-111536

[21]

Linets Yu P, Artyukhov SV, Kazantsev AN, et al. The course of COVID-19 in vaccinated patients. Russian Sklifosovsky Journal “Emergency Medical Care. 2021;10(4):636–641. DOI: 10.23934/2223-9022-2021-10-4-636-641

[22]

Линец Ю. П., Артюхов С.В., Казанцев А.Н. и др. Течение COVID-19 у вакцинированных пациентов // Журнал им. Н.В. Склифосовского Неотложная медицинская помощь. 2021. Т. 10, №. 4. С. 636–641. DOI: 10.23934/2223-9022-2021-10-4-636-641

[23]

Douedi S, Mararenko A, Alshami A, et al. COVID-19 induced bradyarrhythmia and relative bradycardia: An overview. J Arrhythm. 2021;37(4):888–892. DOI: 10.1002/joa3.12578

[24]

Douedi S., Mararenko A., Alshami A., et al. COVID-19 induced bradyarrhythmia and relative bradycardia: An overview // J Arrhythm. 2021. Vol. 37, No. 4. Р. 888–892. DOI: 10.1002/joa3.12578

[25]

Amaratunga EA, Corwin DS, Moran L, Snyder R. Bradycardia in Patients With COVID-19: A Calm Before the Storm? Cureus. 2020;12(6):e8599. DOI: 10.7759/cureus.8599

[26]

Amaratunga E.A., Corwin D.S., Moran L., Snyder R. Bradycardia in Patients With COVID-19: A Calm Before the Storm? // Cureus. 2020. Vol. 12, No. 6. Р. e8599. DOI: 10.7759/cureus.8599

[27]

Grebennikova IV, Lidokhova OV, Makeeva AV, et al. Hematological indices in COVID-19: a retrospective study. Journal of New Medical Technologies. 2022;16(6):87–91. (In Russ.). DOI: 10.24412/2075-4094-2022-6-3-5

[28]

Гребенникова И.В., Лидохова О.В., Макеева А.В., и др. Гематологические индексы при COVID-19: ретроспективное исследование // Вестник новых медицинских технологий. 2022. Т. 16, № 6. С. 87–91. DOI: 10.24412/2075-4094-2022-6-3-5

[29]

Kryukov EV, Trishkin DV, Ivanov AM, et al. Comparative cohort epidemiological study of collective immunity against new coronavirus infection among different groups of military personnel. Annals of the Russian Academy of Medical Sciences. 2021;76(6):661–668. (In Russ.). DOI: 10.15690/vramn1583

[30]

Крюков Е.В., Тришкин Д.В., Иванов А.М., и др. Эпидемиологическое исследование коллективного иммунитета против новой коронавирусной инфекции среди разных групп военнослужащих // Вестник Российской академии медицинских наук. 2021. Т. 76, № 6. С. 661–668. DOI: 10.15690/vramn1583

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

77

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/